Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Our Ask-the-Analyst service is your direct hotline to the team of experts who cover all aspects of the Pharmaceutical market including R&D, clinical trials, market access, financing and licensing. As a Medtrack subscriber, you will receive 24/7 access to our expert analysts who can answer your business development and licensing questions and will provide a
detailed response to your query, spending up to 3 hours per question they receive and will respond within 48 hours, subject to your terms and conditions.
The following examples are actual questions received from Medtrack subscribers, along with their sample responses from the Medtrack analyst team.
Citeline Connect , Citeline
Platform Spans Entire Recruitment Process from Clinical Trial Awareness and Education to Participant Prescreening and Enrollment
Topics Clinical Trials
Accelerate clinical trial cycle times by selecting more site...
This informative whitepaper introduces you to best practices in study feasibility, which laid the groundwork for our new predictive analytic that is launching soon, Citeline Study Feasibility. Our industry-leading technology will deliver advanced insight to improve your clinical trial decisions, fast-track enrollment and optimize cycle times – all with less effort.
Topics Clinical Trials
Citeline Connect
New Informa Pharma Intelligence survey uncovers patient sentiment on clinical trial participation
Topics Clinical Trials
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
